Title: Clinical Profile of Emphysematous Pyelonephritis in Diabetics

Authors: C G Jijumon, Srikantan Sreedharan Pillai

 DOI: https://dx.doi.org/10.18535/jmscr/v7i3.88

Abstract

Introduction: Emphysematous pyelonephritis is a rare but potentially life threatening necrotising renal parenchymal infection characterised by the production of intraparenchymal gas. It is exclusively found in Diabetic patients with a female pre ponderance. In the past, standard treatment was nephrectomy of the affected kidney. The situation has changed dramatically in recent years with CT scan based diagnosis and advancements in multidisciplinary intensive care of sepsis syndrome and MODS. Now the mortality rates has declined to 20%-25%.

Objectives: To study the clinical profile and etiology of emphysematous pyelonephritis among Diabetic patients

Materials and Methods: 50 Diabetic patients with emphysematous pyelonephritis were studied. Clinical profile including etiology were studied.

Results: EPN was more in the elderly diabetics. 44% of the patients were above 65 years. Females constituted the majority (98%). E.Coli was the commonest organism isolated (78.9%) followed by Klebsiella. The overall survival rate was 90%.

Conclusions: EPN was more common in elderly female diabetics. The overall survival rate with medical treatment was good. Mortality was more in patients with bilateral EPN, thrombocytopenia, shock, renal failure and altered mental status.

Keywords: EPN. MODS.

References

  1. Ubee J S, McglynnL, FordhamM. Emphysematous pyelonephritis.. BJU.Int. 2011; 107(9): 1474-78
  2. Lu YC, Hong JH, Chiang BJ, et al. Recommended initial antimicrobial therapy for Emphysematous Pyelonephritis 51 cases and 14 year Experience of a tertiary Referral centre. Medicine (Baltimore). 2016; 95(21); e3573
  3. Ahmad M. Emphysematous pyelonephritis due to Aspergillus fumigates. A Case Report. J. Nephrology.2004; 17 (3); 446-448
  4. Guvel S, Kilinc F, Kayaselsuk F.et al.. Emphysemtous Pyelonephritis and renal amoebiasis in a patient with Diabetes mellitus. Int. J 2003; 10(7); 404-406
  5. Huang JJ, Tseng CC. Emphysematous Pyelonephritis .in clinico radiological classification, Management, Prognosis and Pathogenesis. Arch. Intern Med.2000; 160 (6); 797-805
  6. Crouter AJ, Abraham MK, Wilkerson RG. Emphysematous pyelonephritis in a renal allograft. Am. J .Emerg Med.2017; 35(3);520e1-e2
  7. FathimaR, Jha R Muthukrihnan J et al Emphysematous pyelonephritis. A single center study. Indian J. Nephrology. 2013; 23(2);119-124
  8. Sokhal AK, KumarM, Purkait B. Emphysematous Pyelonephritis. Changing Trend of clinical spectrum, Pathogenesis, Management and outcome .Turkish J. of Urology. 2017;43(2):202-209

Corresponding Author

Srikantan Sreedharan Pillai

Additional Professor of General Medicine, Medical College, Thiruvananthapuram, India

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.